Clairo

Clinical Project Manager

Costa Rica

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor’s degree and/or proven Project Management skills or experience within the pharmaceutical industry, and Clario PM Certification is required as applicable per Line of Business. They must have 1-4 years of experience in project management, along with knowledge of the drug development process, excellent organizational, interpersonal, time management, and prioritization skills, and detail-oriented responsiveness to inquiries.

Responsibilities

The Clinical Project Manager will direct and manage services for client projects to ensure high quality, on-time, and on-budget delivery while promoting excellent customer service, leading the Planning and Setup, Monitoring, and Closeout phases of study management including gathering customer requirements, developing study documentation, distributing equipment, creating reports, and archiving study data. They will also monitor study timelines and manage the financial components of each program/study, including budget reviews, revenue forecasting, and invoice reconciliation, identifying potential risks and mitigations, managing negotiations, and applying problem-solving strategies to address customer issues. Furthermore, they will ensure compliance with training completion, present study services at meetings, assist with training new team members, and perform other duties as needed, while maintaining issue tracking documentation and ensuring timely resolution to customer escalations.

Skills

Project Management
Pharmaceutical Industry Knowledge
Leadership
Organizational Skills
Interpersonal Skills
Time Management
Communication Skills
Microsoft Office
Detail-Oriented
Customer Service
Travel Readiness

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI